CalciMedica, Inc. (CALC) earnings
CALC earnings moved a median of -1.96% by the close. Quarterly and annual CALC reports and results, each read against the price at its own news timestamp. Back to the CALC overview →
23 measured CALC earnings events.
Where these CALC earnings landedvs 21 measured CALC earnings reactions
| Middle 50% of CALC earnings reactions | -3.07% to +4.05% |
|---|---|
| Median reaction (to close) | -1.96% |
| Measured reactions | 21 |
Point-in-time · zero look-ahead
Half of the 21 CALC earnings events with a measured close landed between -3.07% and +4.05%; 38% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| CalciMedica Reports Third Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | Press release | +0.00% | -9.27% | |
| Form 10-Q CalciMedica, Inc. For: Sep 30 | SEC filing · Form 10-Q | +9.42% | -10.14% | |
| CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | Press release | -1.29% | -1.65% | |
| Form 10-Q CalciMedica, Inc. For: Jun 30 | SEC filing · Form 10-Q | -0.61% | -6.08% | |
| CalciMedica Reports First Quarter 2026 Financial Results and Provides Clinical & Corporate Updates | Press release | +0.00% | +2.32% | |
| Form 10-Q CalciMedica, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.45% | +12.56% | |
| Form 10-K/A CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.90% | |
| Form 10-K CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.90% | +5.73% | |
| CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | Press release | +0.62% | +4.05% | |
| Form 10-Q CalciMedica, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.92% | — | |
| CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | Press release | -0.12% | — | |
| Form 10-Q CalciMedica, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -3.07% | |
| CalciMedica Reports First Quarter 2025 Financial Results and Provides Clinical & Corporate Updates | Press release | +0.00% | -2.40% | |
| Form 10-Q CalciMedica, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.00% | -2.51% | |
| Form 10-K CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -3.87% | |
| CalciMedica Reports Third Quarter 2024 Financial Results and Provides Clinical & Corporate Updates | Press release | -1.99% | -3.41% | |
| Form 10-Q CalciMedica, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.98% | +0.60% | |
| CalciMedica Reports Second Quarter 2024 Financial Results and Provides Clinical & Corporate Updates | Press release | — | -1.96% | |
| Form 10-Q CalciMedica, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | -1.96% | |
| CalciMedica Reports First Quarter 2024 Financial Results and Provides Clinical & Corporate Updates | Press release | — | +10.12% | |
| Form 10-Q CalciMedica, Inc. For: Mar 31 | SEC filing · Form 10-Q | — | +10.12% | |
| Form 10-K/A CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | -2.00% | +9.69% | |
| Form 10-K CalciMedica, Inc. For: Dec 31 | SEC filing · Form 10-K | — | -2.00% |
Keep exploring
More CALC: analyst actions → · SEC filings → · CALC overview →